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HPV Immunization in High School
Student-Athletes Receiving
Preparticipation Physical Evaluations
at Mass Event Versus Other Venues
Andrew K. Cunningham, MD,*†‡ Meaghan M. Rourke, AT, ATC,† James L. Moeller, MD,†
and Melissa Nayak, MD†
Background: The preparticipation physical evaluation (PPE) is a requirement for high school sport participation in most
states, but its location and role in preventive health care for adolescents is often questioned.
Hypothesis: Athletes who had their PPE performed in an office setting, in particular) by their primary care physician
(PCP), will have higher human papillomavirus (HPV) immunization rates than those who had their PPE done in a group
setting at a mass-participation PPE.
Study Design: Retrospective cohort study.
Level of Evidence: Level 3.
Methods: The PPE forms and immunization records for athletes at a single high school were reviewed to determine the
location of PPE, the signing practitioner, and HPV immunization status.
Results: A total of 488 athletes (286 males, 202 females) were included; 51% had received at least 1 dose of the HPV
vaccine while 39% had completed the series. There was no significant difference in vaccination rates between examination
in an office setting versus a group setting. Athletes receiving their PPE at an urgent care facility had significantly lower
rates of HPV series completion than all other settings (29% vs 43%; P = 0.004). PPE completion by the athlete’s PCP was
associated with higher rates of vaccine series completion (46% vs 34%; P = 0.014).
Conclusion: Athletes who completed their PPE in mass event and office-based settings had similar rates of HPV vaccine
series initiation and completion. PPEs done at urgent care facilities were associated with low rates of vaccine series
completion, while those done by a PCP were associated with higher rates.
Clinical Relevance: HPV immunization rates in athletes are low, and the PPE represents a potential opportunity to
improve immunization rates.
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T

he human papillomavirus (HPV) vaccine is recommended
for both boys and girls between the ages of 9 and 26 years
but is usually started at 11 to 12 years of age. The vaccine
is administered in a 2-dose series, ideally given 6 to 12 months
apart. If given after the age of 14 years, a third dose is required
for vaccine completion.10 The purpose of the HPV vaccine is
mainly to prevent cervical and oropharyngeal cancers attributed

to HPV infection. While HPV vaccination is recommended by the
Advisory Committee on Immunization Practices of the Centers
for Disease Control and Prevention, it is not currently required
for school attendance in Michigan,5,10 and it is well-known that
HPV immunization rates have trailed those of required vaccines.
In 2017, only 65.5% of 13- to 17-year-old American boys and
girls were current with their first HPV vaccination, and 48.6%
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had completed the series.11 Some critics believe that the
preparticipation physical evaluation (PPE) is of little benefit
when performed outside of the medical home and have
questioned its role altogether.4,8 The 2019-released PPE (Fifth
Edition) prefers that the PPE be performed in the medical home.1
One benefit of the office-based PPE is that traditional
well-child/preventive care can be addressed.7 At a typical
well-child examination, vaccine review and administration are
standard. Immunizations are a vital aspect of preventive care
and should be equally important in the care of athletes.2 Many
students utilize school-sponsored mass PPEs, and vaccines are
not typically offered at these venues. At our particular
institution, we conduct yearly mass PPEs with the schools we
cover. These examinations consist of brief orthopaedic and
medical screening exams, as well as a medical history
questionnaire review and are typically conducted in a
gymnasium or locker room. Immunizations are not administered
in this setting. It is currently unknown how many students forgo
visits with their primary care physician (PCP) in lieu of
mass-participation PPEs and may miss vaccine opportunities.
Furthermore, many students may opt to have their PPE
performed at urgent care or retail medical facilities.
One prior study suggested that there are low rates of receipt
of all recommended immunizations in high school athletes,3 but
little has been published on HPV vaccination specifically for this
population. Our objective was to determine whether there were
differences in HPV immunization rates depending on location of
PPE.

Methods
Study Design
We conducted a retrospective cohort study of the HPV
immunization status of high school athletes at a single high
school in Michigan with whom we provide athletic training and
sports medicine coverage. Our group sponsored a station-based
mass PPE event at this school.
Data Collection
We retrospectively reviewed the state-required PPE forms for all
althetes participating in fall and winter sports for the 2018-2019
school year.6 These forms were used to identify the venue of
examination (office vs mass event) and the signing practitioner
(PCP vs other). Additionally, we identified whether an
examination form was completed at one of the many known
local urgent care facilities. Immunization records were reviewed
through the statewide database, and we recorded whether each
athlete had received any doses of an HPV vaccine (≥1) and
whether they had completed the series.
Outcome Measures
The primary analysis conveyed a difference in rates of receipt of
≥1 dose of HPV vaccine in office-based versus mass event
physicals. Secondary analyses were vaccine series completion
and differences in vaccine receipt based on age, sex,
2

Table 1. Location of examination
Venue

n (%)

Office

424 (86.9)

PCP

169 (34.6)

UC

147 (30.1)

Non-UC, non-PCP

108 (22.2)

Group

64 (13.1)

PCP, primary care physician; UC, urgent care.

examination by PCP versus another provider, and examination
at an urgent care facility.
Statistical Analysis
Groups were compared using chi-square tests with a 2-sided
alpha of 0.05 for an 80% power to detect a difference in
vaccination rates of 15%. We estimated that 60% of athletes
received at least 1 dose of HPV vaccine in office-based
examinations. We estimated a sample size of 508 athletes,
assuming 406 and 102 in the office-based and mass event
groups, respectively.

Results
A total of 488 student-athlete PPE forms and immunization records
were reviewed: 64 examinations (13%) were performed in the
mass event group setting and 424 (87%) were done in an office
setting. Of these, 147 examinations (30%) were completed at
known urgent care facilities, and 169 (35%) were performed by
the listed PCP. The remaining 108 examinations were assumed to
be done in an office setting of some type. In these cases,
examinations were performed by a provider other than the listed
PCP, or the PCP was not listed (Table 1).
Those seen in office and group settings had no statistically
significant differences in age, sex, receipt of at least 1 HPV
vaccine dose, or vaccine series completion. There was no
statistically significant difference in those who received at least a
single dose of the HPV vaccine based on age, sex, location
(office vs group), or form completion by PCP versus non-PCP.
Vaccine series completion was higher in those who had their
forms completed by their PCP versus non-PCP (46% vs 33%;
P = 0.014). Those seen in urgent care facilities had the lowest
rates of vaccine series completion (29.3%) compared with those
seen in the group or other office-based settings, both of which
were statistically significant (Table 2).

Discussion
In this convenience sample of high school athletes, HPV vaccine
rates (both series initiation and series completion) did not differ
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Table 2. HPV initiation/completiona
HPV Series Complete
vs Incomplete

Variable

Response (Total)

HPV ≥1 vs 0

Age, y

Mean
Median (Q25, Q75)

15.6 (1.2)
15.5 (15, 17)

0.235

15.6 (1.2)
15 (15, 16)

0.632

Sex

Male (n = 286)

153 (53.5)

0.270

116 (40.6)

0.381

Location

Female (n = 202)

97 (48.0)

Mass event (n = 64)

32 (50.0)

Office (n = 424)
PCP

PCP (n = 169)
Non-PCP (n = 272)

UC

Office location

95 (56.2)

0.833

No (n = 322)

176 (54.7)

UC (n = 147)

65 (44.2)

23 (35.9)

0.598

167 (39.4)
0.062

128 (47.1)
65 (44.2)

P

74 (36.6)

218 (51.4)

Yes (n = 147)

Office, non-UC (n = 277)

P

77 (45.6)

0.014

92 (33.8)
0.036

43 (29.3)

0.004

139 (43.2)
0.095

153 (55.2)

43 (29.3)

0.007

124 (44.8)

HPV, human papillomavirus; PCP, primary care physician; UC, urgent care.
a
All values, except for age, are given as n (%). Boldfaced P values indicate statistical significance (P < .05).

for those who received their examination at a school-sponsored
mass event compared with other locations. Overall, 51% of
athletes had at least started their HPV series, while 39% had
completed the series.
Examination in an urgent care setting was associated with
lower rates of both HPV vaccine initiation and completion.
Those who received their examination by the listed PCP were
found to have the highest rates of HPV series completion (46%),
which was statistically significant.
This study has multiple limitations. First, it is a sample of a
single high school and subject to the demographic limitations
therein. The school studied is a public high school in suburban
metropolitan Detroit, Michigan, with a population of 27,076
people, of which 93% are white, and a median household
income of $69,134.9 Socioeconomic demographics were not
addressed in our study. Another limitation of a single-school
population is that this cohort would be more likely to be
influenced by the vaccine practices/tendencies of a handful of
practices/providers that serve the community. The
aforementioned limit the generalizability of these results.
This study does not account for whether athletes were seen
for a well-child/preventive visit during the school year in
question, and there is likely a large degree of overlap in those
groups. The number of athletes who attended the massparticipation event and still had a traditional preventive care
visit is unknown. Interestingly, our results may suggest that
those who attended the group physical were more likely to
receive preventive care than those who sought care at an urgent

care facility. It is possible that these athletes were less likely to
view the mass event examination as a substitute for their
well-child examination as opposed to those seen at an urgent
care. Those seen in the urgent care setting had the overall
lowest vaccine rates, which may suggest that they are foregoing
their well-child/preventive visits in lieu of care at retail medical
clinics, which may or may not be addressing vaccine status.
Additionally, the medical home is not the only venue in which
vaccines can be administered, as immunizations are often given
at pharmacies or the local health department.
One strength of this study is its size and confirmation of
vaccination status through state immunization record review,
which captures vaccine administration anywhere in the state. To
our knowledge, this is the largest published data set regarding
HPV immunization rates in high school athletes. Prior studies
involving athletes have primarily relied on survey data and are
prone to recall bias.

Conclusion
Within a single high school in Michigan, 51% of all athletes had
received at least 1 dose of an HPV vaccine, while 39% had
completed the series. A PPE performed by a PCP was associated
with immunization status being up to date compared with that
of an urgent care setting. This study further highlights the
importance of routinely addressing the immunization status of
adolescents at any office visit and demonstrates that the PPE,
particularly done in the mass event setting or at an urgent care,
3
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should not be thought of as a substitute for a traditional
preventive health care visit. Ideally, the PPE would be
performed by the PCP in the athlete’s medical home, where
immunization records can be reviewed and any deficiencies
addressed.
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